{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T17:07:02Z","timestamp":1794503222461,"version":"4.9.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Ther"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s40120-023-00504-6","type":"journal-article","created":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T12:02:23Z","timestamp":1685620943000},"page":"1257-1284","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["A Systematic Review of Clinical Practice Guidelines for Alzheimer\u2019s Disease and Strategies for Future Advancements"],"prefix":"10.1007","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4003-3192","authenticated-orcid":false,"given":"Amir Abbas","family":"Tahami Monfared","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3603-1736","authenticated-orcid":false,"given":"N. T. Nhan","family":"Phan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3931-8457","authenticated-orcid":false,"given":"Isobel","family":"Pearson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6098-5548","authenticated-orcid":false,"given":"Josephine","family":"Mauskopf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4696-0173","authenticated-orcid":false,"given":"Min","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanwu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0894-8982","authenticated-orcid":false,"given":"Harald","family":"Hampel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,1]]},"reference":[{"key":"504_CR1","unstructured":"National Institues of Health. What are clinical practice guidelines? National Library of Medicine; 2023. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK390308\/. Accessed 6 Jan 2023."},{"key":"504_CR2","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/978-1-0716-1138-8_24","volume":"2249","author":"TW Yi","year":"2021","unstructured":"Yi TW, Donnellan S, Levin A. Evidence-based decision making 4: clinical practice guidelines. Methods Mol Biol. 2021;2249:455\u201366.","journal-title":"Methods Mol Biol"},{"issue":"11","key":"504_CR3","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/S1474-4422(10)70223-4","volume":"9","author":"B Dubois","year":"2010","unstructured":"Dubois B, Feldman HH, Jacova C, et al. Revising the definition of Alzheimer\u2019s disease: a new lexicon. Lancet Neurol. 2010;9(11):1118\u201327.","journal-title":"Lancet Neurol"},{"issue":"3","key":"504_CR4","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jalz.2016.02.002","volume":"12","author":"B Dubois","year":"2016","unstructured":"Dubois B, Hampel H, Feldman HH, et al. Preclinical Alzheimer\u2019s disease: definition, natural history, and diagnostic criteria. Alzheimers Dement. 2016;12(3):292\u2013323.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"504_CR5","doi-asserted-by":"publisher","first-page":"4168","DOI":"10.1038\/s41598-021-83585-3","volume":"11","author":"SH Cho","year":"2021","unstructured":"Cho SH, Woo S, Kim C, et al. Disease progression modelling from preclinical Alzheimer\u2019s disease (AD) to AD dementia. Sci Rep. 2021;11(1):4168.","journal-title":"Sci Rep"},{"issue":"3","key":"504_CR6","first-page":"371","volume":"8","author":"AP Porsteinsson","year":"2021","unstructured":"Porsteinsson AP, Isaacson RS, Knox S, Sabbagh MN, Rubino I. Diagnosis of early Alzheimer\u2019s disease: clinical practice in 2021. J Prev Alzheimers Dis. 2021;8(3):371\u201386.","journal-title":"J Prev Alzheimers Dis"},{"issue":"7","key":"504_CR7","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1093\/brain\/awy132","volume":"141","author":"H Hampel","year":"2018","unstructured":"Hampel H, Mesulam MM, Cuello AC, et al. The cholinergic system in the pathophysiology and treatment of Alzheimer\u2019s disease. Brain. 2018;141(7):1917\u201333.","journal-title":"Brain"},{"issue":"10","key":"504_CR8","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","volume":"26","author":"H Hampel","year":"2021","unstructured":"Hampel H, Hardy J, Blennow K, et al. The amyloid-beta pathway in Alzheimer\u2019s disease. Mol Psychiatry. 2021;26(10):5481\u2013503.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"504_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12295","volume":"8","author":"J Cummings","year":"2022","unstructured":"Cummings J, Lee G, Nahed P, et al. Alzheimer\u2019s disease drug development pipeline: 2022. Alzheimers Dement (N Y). 2022;8(1): e12295.","journal-title":"Alzheimers Dement (N Y)"},{"issue":"2","key":"504_CR10","first-page":"109","volume":"4","author":"J Cummings","year":"2017","unstructured":"Cummings J, Fox N. Defining disease modifying therapy for Alzheimer\u2019s disease. J Prev Alzheimers Dis. 2017;4(2):109\u201315.","journal-title":"J Prev Alzheimers Dis"},{"issue":"8","key":"504_CR11","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/s43587-022-00269-x","volume":"2","author":"H Hampel","year":"2022","unstructured":"Hampel H, Au R, Mattke S, et al. Designing the next-generation clinical care pathway for Alzheimer\u2019s disease. Nat Aging. 2022;2(8):692\u2013703.","journal-title":"Nat Aging"},{"issue":"6","key":"504_CR12","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/S1474-4422(21)00066-1","volume":"20","author":"B Dubois","year":"2021","unstructured":"Dubois B, Villain N, Frisoni GB, et al. Clinical diagnosis of Alzheimer\u2019s disease: recommendations of the International Working Group. Lancet Neurol. 2021;20(6):484\u201396.","journal-title":"Lancet Neurol"},{"issue":"2","key":"504_CR13","first-page":"221","volume":"9","author":"J Cummings","year":"2022","unstructured":"Cummings J, Rabinovici GD, Atri A, et al. Aducanumab: appropriate use recommendations update. J Prev Alzheimers Dis. 2022;9(2):221\u201330.","journal-title":"J Prev Alzheimers Dis"},{"key":"504_CR14","doi-asserted-by":"crossref","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;21;6(7):e1000097.","DOI":"10.1371\/journal.pmed.1000097"},{"issue":"4","key":"504_CR15","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr, Bennett DA, Blennow K, et al. NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 2018;14(4):535\u201362.","journal-title":"Alzheimers Dement"},{"issue":"2","key":"504_CR16","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1007\/s00259-021-05603-w","volume":"49","author":"E Guedj","year":"2022","unstructured":"Guedj E, Varrone A, Boellaard R, et al. EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3. Eur J Nucl Med Mol Imaging. 2022;49(2):632\u201351.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"504_CR17","first-page":"292","volume":"15","author":"LK Huang","year":"2021","unstructured":"Huang LK, Chiu PY, Yeh YC, et al. Taiwan Dementia treatment guideline. Int J Gerontol. 2021;15(4):292\u2013300.","journal-title":"Int J Gerontol"},{"key":"504_CR18","doi-asserted-by":"crossref","unstructured":"International clinical practice guideline of Chinese Medicine Alzheimer. World J Tradit Chin Med. 2021;7(2):265\u201375.","DOI":"10.4103\/wjtcm.wjtcm_28_21"},{"issue":"4","key":"504_CR19","doi-asserted-by":"publisher","first-page":"174","DOI":"10.5694\/mja2.50015","volume":"210","author":"E Reeve","year":"2019","unstructured":"Reeve E, Farrell B, Thompson W, et al. Deprescribing cholinesterase inhibitors and memantine in dementia: guideline summary. Med J Aust. 2019;210(4):174\u20139.","journal-title":"Med J Aust"},{"issue":"3","key":"504_CR20","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1212\/WNL.0000000000004826","volume":"90","author":"RC Petersen","year":"2018","unstructured":"Petersen RC, Lopez O, Armstrong MJ, et al. Practice guideline update summary: mild cognitive impairment report of the guideline development, dissemination, and implementation. Neurology. 2018;90(3):126\u201335.","journal-title":"Neurology"},{"issue":"Suppl 3","key":"504_CR21","doi-asserted-by":"publisher","first-page":"S312","DOI":"10.4103\/0019-5545.224472","volume":"60","author":"KS Shaji","year":"2018","unstructured":"Shaji KS, Sivakumar PT, Rao GP, Paul N. Clinical practice guidelines for management of dementia. Indian J Psychiatry. 2018;60(Suppl 3):S312\u201328.","journal-title":"Indian J Psychiatry"},{"key":"504_CR22","doi-asserted-by":"crossref","unstructured":"Lee JS, Kim GH, Kim HJ, et al. Clinical practice guideline for dementia (diagnosis and evaluation): 2021 revised edition. Dement Neurocogn Disord. 2022;21(1):42\u20134.","DOI":"10.12779\/dnd.2022.21.1.42"},{"key":"504_CR23","unstructured":"National Institute for Health and Care Excellence. Dementia: assessment, management and support for people living with dementia and their carers. 2018. https:\/\/www.nice.org.uk\/guidance\/ng97\/resources\/dementia-assessment-management-and-support-for-people-living-with-dementia-and-their-carers-pdf-1837760199109."},{"key":"504_CR24","unstructured":"Reeve E, Farrell B, Thompson W, et al. Evidence-based clinical practice guideline for deprescribing cholinesterase inhibitors and memantine in people with dementia. Recommendations The University of Sydney, Sydney, Australia. 2018."},{"key":"504_CR25","unstructured":"Danish Health Authority. National clinical guideline on dementia and medicine. 2018. https:\/\/www.sst.dk\/-\/media\/Udgivelser\/2018\/NKR-medicin-og-demens\/EN\/Quick-Guide-NKR-demens-og-medicin_EN.ashx. Accessed 16 June 2022."},{"key":"504_CR26","unstructured":"Department of Health Dublin. Appropriate prescribing of psychotropic medication for non-cognitive symptoms in people with dementia. National clinical guideline no. 21; 2019. https:\/\/www.gov.ie\/en\/collection\/ac0046-appropriate-prescribing-of-psychotropic-medication-for-non-cognitive\/. Accessed 17 June 2022."},{"key":"504_CR27","unstructured":"Ministry of Health Malaysia. Clinical practice guidelines: management of dementia. 2021."},{"key":"504_CR28","unstructured":"Foley T, Jennings A, Swanwick G. Dementia: diagnosis & management in general practice: ICGP Quality and Safety in Practice Committee. 2019."},{"key":"504_CR29","unstructured":"World Health Organization. Risk reduction of cognitive decline and dementia: WHO guidelines. January 1, 2019. 2022. https:\/\/www.who.int\/publications\/i\/item\/9789241550543. Accessed 17 June."},{"key":"504_CR30","unstructured":"Danish Health Authority. National clinical guideline for diagnosis of mild cognitive impairment and dementia. 2018. https:\/\/www.sundhedsstyrelsen.dk\/-\/media\/Udgivelser\/2018\/NKR-Diagnostik-af-mild-cognitive-impairment-og-demens\/Quick-guide---National-Clinical-Guideline-for-Diafnosis-of-Mild-Cognitive-Impairment-and-Dementia.ashx?sc_lang=da&hash=AEAEFA87F77D7D3E2C49400F2ED7A228. Accessed 16 June 2022."},{"issue":"4","key":"504_CR31","first-page":"374","volume":"40","author":"MP Janicki","year":"1996","unstructured":"Janicki MP, Heller T, Seltzer GB, Hogg J. Practice guidelines for the clinical assessment and care management of Alzheimer\u2019s disease and other dementias among adults with intellectual disability. J Intellect Disabil Res. 1996;40(4):374\u201382.","journal-title":"J Intellect Disabil Res"},{"key":"504_CR32","unstructured":"Fillit H, Cummings J. Disease management. Practice guidelines for the diagnosis and treatment of Alzheimer's disease in a managed care setting: part I\u2014early detection and diagnosis...in part II, and the conclusion of this article, which will appear next month, the authors describe the pharmacologic treatment guidelines designed by the Alzheimer's Disease Managed Care Advisory Council. Managed Care Interface. 1999;12(12):53\u201362."},{"key":"504_CR33","unstructured":"Ministry of Health Singapore. Dementia. 2013. https:\/\/www.moh.gov.sg\/docs\/librariesprovider4\/guidelines\/dementia-10-jul-2013---booklet.pdf. Accessed 16 June 2022."},{"issue":"2","key":"504_CR34","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1177\/1533317512470209","volume":"28","author":"I Arevalo-Rodriguez","year":"2013","unstructured":"Arevalo-Rodriguez I, Pedraza OL, Rodr\u00edguez A, et al. Alzheimer\u2019s disease dementia guidelines for diagnostic testing: a systematic review. Am J Alzheimers Dis Other Demen. 2013;28(2):111\u20139.","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"504_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.719849","volume":"12","author":"YX Chen","year":"2021","unstructured":"Chen YX, Liang N, Li XL, Yang SH, Wang YP, Shi NN. Diagnosis and treatment for mild cognitive impairment: a systematic review of clinical practice guidelines and consensus statements. Front Neurol. 2021;12: 719849.","journal-title":"Front Neurol"},{"issue":"372","key":"504_CR36","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"29","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;29(372): n71.","journal-title":"BMJ"},{"issue":"9","key":"504_CR37","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/s41582-021-00520-w","volume":"17","author":"H Hampel","year":"2021","unstructured":"Hampel H, Cummings J, Blennow K, Gao P, Jack CR Jr, Vergallo A. Developing the ATX(N) classification for use across the Alzheimer disease continuum. Nat Rev Neurol. 2021;17(9):580\u20139.","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"504_CR38","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1080\/14737159.2020.1731306","volume":"20","author":"F Baldacci","year":"2020","unstructured":"Baldacci F, Mazzucchi S, Della Vecchia A, et al. The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseases. Expert Rev Mol Diagn. 2020;20(4):421\u201341.","journal-title":"Expert Rev Mol Diagn"},{"issue":"5","key":"504_CR39","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.mcna.2020.06.007","volume":"104","author":"L McCollum","year":"2020","unstructured":"McCollum L, Karlawish J. Cognitive impairment evaluation and management. Med Clin N Am. 2020;104(5):807\u201325.","journal-title":"Med Clin N Am"},{"issue":"4","key":"504_CR40","first-page":"398","volume":"8","author":"J Cummings","year":"2021","unstructured":"Cummings J, Aisen P, Apostolova LG, Atri A, Salloway S, Weiner M. Aducanumab: appropriate use recommendations. J Prev Alzheimers Dis. 2021;8(4):398\u2013410.","journal-title":"J Prev Alzheimers Dis"},{"issue":"7","key":"504_CR41","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1748-5908-7-62","volume":"4","author":"P Shekelle","year":"2012","unstructured":"Shekelle P, Woolf S, Grimshaw JM, Schunemann HJ, Eccles MP. Developing clinical practice guidelines: reviewing, reporting, and publishing guidelines; updating guidelines; and the emerging issues of enhancing guideline implementability and accounting for comorbid conditions in guideline development. Implement Sci. 2012;4(7):62.","journal-title":"Implement Sci"},{"issue":"1","key":"504_CR42","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jclinepi.2013.06.021","volume":"67","author":"M Becker","year":"2014","unstructured":"Becker M, Neugebauer EA, Eikermann M. Partial updating of clinical practice guidelines often makes more sense than full updating: a systematic review on methods and the development of an updating procedure. J Clin Epidemiol. 2014;67(1):33\u201345.","journal-title":"J Clin Epidemiol"},{"issue":"17","key":"504_CR43","doi-asserted-by":"publisher","first-page":"e879","DOI":"10.1161\/CIR.0000000000000651","volume":"139","author":"GN Levine","year":"2019","unstructured":"Levine GN, O\u2019Gara PT, Beckman JA, et al. Recent innovations, modifications, and evolution of ACC\/AHA clinical practice guidelines: an update for our constituencies: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139(17):e879\u201386.","journal-title":"Circulation"},{"issue":"05","key":"504_CR44","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1055\/s-0034-1385158","volume":"35","author":"F Ingravallo","year":"2014","unstructured":"Ingravallo F, Dietrich C, Gilja O, Piscaglia F. Guidelines, clinical practice recommendations, position papers and consensus statements: definition, preparation, role and application. Ultraschall Med. 2014;35(05):395\u20139.","journal-title":"Ultraschall Med"}],"container-title":["Neurology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-023-00504-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40120-023-00504-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-023-00504-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T17:15:54Z","timestamp":1729530954000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40120-023-00504-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,1]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["504"],"URL":"https:\/\/doi.org\/10.1007\/s40120-023-00504-6","relation":{},"ISSN":["2193-8253","2193-6536"],"issn-type":[{"value":"2193-8253","type":"print"},{"value":"2193-6536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,1]]},"assertion":[{"value":"20 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}